• Mouse TNFRSF5 (Tumor Necrosis Factor Receptor Superfamily, Member 5) Sandwich ELISA Kit Ready-To-Use (STJE0006863)

Mouse TNFRSF5 (Tumor Necrosis Factor Receptor Superfamily, Member 5) Sandwich ELISA Kit Ready-To-Use (STJE0006863)

SKU:
STJE0006863

Shipping:
Free Shipping
Current Stock:
Applications: ELISA
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Sensitivity: 5.4pg/mL
Detection Limit: 15.6-1000pg/mL
Short Description: This TNFRSF5 Sandwich ELISA Kit, Ready-To-Use is an in-vitro enzyme-linked immunosorbent assay for the measurement of samples in mouse cell culture supernatant, serum and plasma (EDTA, citrate, heparin).
Storage Instruction: Store the unopened kit in the fridge at 2-8°C for up to 6 months. Once opened store individual kit contents according to components table provided with the kit.
Assay Time: 3 hrs
Gene Symbol: Cd40
Gene ID: 21939
Uniprot ID: TNR5_MOUSE
Immunogen Region: Ready-To-Use
Sample Type: serum, plasma or other biological fluids.
Tissue Specificity
Post Translational Modifications
Function Receptor for TNFSF5/CD40LG. Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion.
Protein Name Tumor Necrosis Factor Receptor Superfamily Member 5
B-Cell Surface Antigen Cd40
Bp50
Cd40l Receptor
Cd Antigen Cd40
Database Links Reactome: R-MMU-198933
Reactome: -MMU-5668541
Reactome: -MMU-5676594
Cellular Localisation Isoform I: Cell Membrane
Single-Pass Type I Membrane Protein
Isoform Iii: Cell Membrane
Isoform Iv: Cell Membrane
Isoform V: Cell Membrane
Isoform Ii: Secreted
Alternative ELISA Names Tumor Necrosis Factor Receptor Superfamily Member 5 ELISA kit
B-Cell Surface Antigen Cd40 ELISA kit
Bp50 ELISA kit
Cd40l Receptor ELISA kit
Cd Antigen Cd40 ELISA kit
Cd40 ELISA kit
Tnfrsf5 ELISA kit
output

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance